+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dermatology Drugs Market - Global Forecast 2026-2032- Product Image
Dermatology Drugs Market - Global Forecast 2026-2032- Product Image
New

Dermatology Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5967940
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dermatology drugs market is rapidly transforming as advanced therapies and digital integration reshape how conditions are managed across clinical and commercial landscapes. Demand is increasing globally, with evolving expectations among patients, regulators, and payers influencing product development and access.

Market Snapshot: Dermatology Drugs Market Growth and Outlook

The Dermatology Drugs Market grew from USD 37.71 billion in 2025 to USD 41.56 billion in 2026. It is expected to continue growing at a CAGR of 10.25%, reaching USD 74.71 billion by 2032. This robust expansion reflects accelerated innovation and heightened focus on addressing chronic skin diseases, with biologics and targeted small molecules gaining market traction.

Scope & Segmentation of the Dermatology Drugs Market

This report examines the comprehensive landscape of dermatology therapeutics, with detailed segmentation and analysis across multiple categories:

  • Routes of Administration: Injectable (biologics and small molecules), oral, and topical formats.
  • Drug Classes: Includes biologics (anti-TNF, IL-17, IL-23 inhibitors), calcineurin inhibitors, corticosteroids, PDE4 inhibitors, and retinoids, each varying in development and commercial challenges.
  • Indications: Acne, atopic dermatitis, psoriasis (guttate, inverse, plaque), rosacea, vitiligo, and other chronic and inflammatory skin conditions.
  • Distribution Channels: Hospital pharmacy, retail pharmacy, online pharmacy (both over-the-counter and prescription-enabled), each demanding tailored market access strategies.
  • Patient Age Cohorts: Adults, geriatrics, and pediatrics, including subcategories for adolescents, children, and infants, with dedicated dosing and safety considerations.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, with each region presenting unique regulatory, reimbursement, and infrastructure nuances.
  • Technology Integration: Coverage includes telemedicine, digital monitoring, advanced biologic manufacturing, formulation science, and supply chain risk mitigation measures.

Key Takeaways for Senior Decision-Makers

  • The shift toward precision medicine continues, with biologics and selective small molecules redefining standards of care for immune-mediated skin diseases.
  • Teledermatology and digital adherence tools are supporting earlier diagnosis and creating new, efficient channels for patient engagement and real-world evidence generation.
  • Supply chains are being restructured to emphasize regional manufacturing, multi-sourcing, and risk reduction in response to rising input costs and logistical unpredictability.
  • Payer demands are evolving, with heightened scrutiny on comparative effectiveness and value-based outcomes, prompting the need for robust real-world data and patient-reported evidence to gain access.
  • Market segmentation by indication, route, and age cohort remains essential for tailoring product development and maximizing real-world impact, especially given variability in adherence and clinical outcomes.

Tariff Impact on Dermatology Drug Supply Chains

Tariff policies are influencing every stage of dermatology drug production. Increased duties on ingredients and packaging compel pharmaceutical firms to adjust manufacturing footprints and diversify supplier bases, often accelerating regionalization to control costs and secure supply continuity. These shifts require forward-looking sourcing strategies and investment in domestic and regional capacity. Manufacturers are also engaging policymakers and payers to offset acquisition cost pressures and to safeguard equitable patient access in a dynamic tariff environment.

Methodology & Data Sources in the Dermatology Drugs Market

This report uses a robust, multi-method research approach, combining primary interviews with clinicians, payers, supply chain professionals, and commercial leaders. Insights are verified through systematic reviews of regulatory and clinical evidence, alongside market and supply chain scenario analyses. Ongoing expert validation ensures actionable and reliable guidance.

Why This Report Matters

  • Identify precise commercial opportunities and risk mitigation strategies shaped by technological, regulatory, and regional trends.
  • Gain insights into pressing challenges for market access, including evolving payer requirements and patient-centric innovation.
  • Equip your organization to optimize portfolio, enhance supply chain resilience, and accelerate access to new therapies.

Conclusion

The dermatology drugs market is advancing through scientific, regulatory, and commercial changes. Strategic planning focused on integration of innovation, robust evidence, and regional adaptation will strengthen competitive positioning and deliver enduring value for patients and stakeholders.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Dermatology Drugs Market, by Drug Class
8.1. Biologics
8.1.1. Anti-Tnf
8.1.2. Il-17 Inhibitors
8.1.3. Il-23 Inhibitors
8.2. Calcineurin Inhibitors
8.3. Corticosteroids
8.4. Pde4 Inhibitors
8.5. Retinoids
9. Dermatology Drugs Market, by Route Of Administration
9.1. Injectable
9.1.1. Biologics
9.1.2. Small Molecules
9.2. Oral
9.3. Topical
9.3.1. Cream
9.3.2. Foam
9.3.3. Gel
9.3.4. Lotion
9.3.5. Ointment
10. Dermatology Drugs Market, by Indication
10.1. Acne
10.2. Atopic Dermatitis
10.3. Psoriasis
10.3.1. Guttate Psoriasis
10.3.2. Inverse Psoriasis
10.3.3. Plaque Psoriasis
10.4. Rosacea
10.5. Vitiligo
11. Dermatology Drugs Market, by Patient Age Group
11.1. Adult
11.2. Geriatrics
11.3. Pediatrics
11.3.1. Adolescent
11.3.2. Child
11.3.3. Infant
12. Dermatology Drugs Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.2.1. Over The Counter
12.2.2. Prescription Drugs
12.3. Retail Pharmacy
13. Dermatology Drugs Market, by End User
13.1. Hospitals
13.2. Speciality Clinics
13.3. Cosmetic Centres
14. Dermatology Drugs Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Dermatology Drugs Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Dermatology Drugs Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Dermatology Drugs Market
18. China Dermatology Drugs Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Allergan plc by Abbvie Inc.
19.6. Almirall S.A.
19.7. Amgen Inc.
19.8. Arcutis Biotherapeutics, Inc.
19.9. Asterisk Laboratories
19.10. AstraZeneca plc
19.11. Bayer AG
19.12. Bristol-Myers Squibb Company
19.13. Cipla Limited
19.14. Concert Pharmaceuticals by Sun Pharmaceutical Industries Limited
19.15. DermBiont, Inc.
19.16. Dr. Reddy's Laboratories
19.17. Eli Lilly and Company
19.18. F. Hoffmann-La Roche AG
19.19. Galderma S.A.
19.20. GlaxoSmithkline plc
19.21. Johnson & Johnson Services, Inc.
19.22. Leo Pharma A/S
19.23. Lupin Ltd
19.24. Mayne Pharma Group Ltd
19.25. Merck & Co., Inc
19.26. Novartis AG
19.27. Pfizer Inc.
19.28. Roivant Sciences Ltd.
19.29. Shinom Cosmeceuticals
List of Figures
FIGURE 1. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DERMATOLOGY DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DERMATOLOGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DERMATOLOGY DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTI-TNF, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTI-TNF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTI-TNF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-17 INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-17 INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-17 INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-23 INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-23 INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-23 INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY FOAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY FOAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GUTTATE PSORIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GUTTATE PSORIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GUTTATE PSORIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INVERSE PSORIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INVERSE PSORIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INVERSE PSORIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROSACEA, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROSACEA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROSACEA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY VITILIGO, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY VITILIGO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY VITILIGO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GERIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADOLESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADOLESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CHILD, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CHILD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CHILD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INFANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INFANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INFANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COSMETIC CENTRES, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COSMETIC CENTRES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COSMETIC CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 191. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 193. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 196. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 199. EUROPE DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 215. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 216. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 217. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 218. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 219. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 220. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 221. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 222. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 223. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 225. AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 242. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 243. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 244. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 245. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 246. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 247. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 248. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 250. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 252. ASEAN DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. GCC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. GCC DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 255. GCC DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 256. GCC DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 257. GCC DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 258. GCC DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 259. GCC DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 260. GCC DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 261. GCC DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 262. GCC DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 263. GCC DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 264. GCC DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 265. GCC DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 281. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 282. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 283. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 284. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 285. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 286. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 287. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 288. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 289. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 290. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 291. BRICS DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. G7 DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 293. G7 DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 294. G7 DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 295. G7 DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 296. G7 DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 297. G7 DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 298. G7 DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 299. G7 DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 300. G7 DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 301. G7 DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 302. G7 DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 303. G7 DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 304. G7 DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. NATO DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 306. NATO DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 307. NATO DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 308. NATO DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 309. NATO DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 310. NATO DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 311. NATO DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 312. NATO DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 313. NATO DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 314. NATO DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 315. NATO DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. NATO DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 317. NATO DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 318. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 321. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 323. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 324. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 325. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 326. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 327. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 330. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 332. CHINA DERMATOLOGY DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 334. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 335. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 336. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 337. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 338. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 339. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2032 (USD MILLION)
TABLE 340. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 341. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 342. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 343. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 344. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Dermatology Drugs market report include:
  • Allergan plc by Abbvie Inc.
  • Almirall S.A.
  • Amgen Inc.
  • Arcutis Biotherapeutics, Inc.
  • Asterisk Laboratories
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Concert Pharmaceuticals by Sun Pharmaceutical Industries Limited
  • DermBiont, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Galderma S.A.
  • GlaxoSmithkline plc
  • Johnson & Johnson Services, Inc.
  • Leo Pharma A/S
  • Lupin Ltd
  • Mayne Pharma Group Ltd
  • Merck & Co., Inc
  • Novartis AG
  • Pfizer Inc.
  • Roivant Sciences Ltd.
  • Shinom Cosmeceuticals

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 41.56 Billion
Forecasted Market Value ( USD ) by 2032 $ 74.71 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Dermatology Drugs - Global Strategic Business Report - Product Image

Dermatology Drugs - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Dermatological Therapeutics Market - Global Forecast 2026-2032 - Product Image

Dermatological Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Global Forecast 2026-2032 - Product Image

Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Prescription Dermatology Therapeutics - Global Strategic Business Report - Product Image

Prescription Dermatology Therapeutics - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Inflammatory Skin Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Inflammatory Skin Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Dermatological Drugs Market

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.